P659: Whole-genome sequencing as a first assay has the potential to shorten diagnosis time for neurodevelopmental disorders

• Kate Im,
• Pauline Ng,
• Premal Shah,
• Matthew Rabinowitz,
• Brynn Levy,
• Akash Kumar

Affiliations

Kate Im

MyOme, Inc.

Pauline Ng

MyOme, Inc.

Premal Shah

MyOme, Inc.

Matthew Rabinowitz

MyOme, Inc., Natera, Inc.

Brynn Levy

MyOme, Inc.; Columbia University

Akash Kumar

MyOme, Inc.